Copyright
©The Author(s) 2017.
World J Gastroenterol. Jul 14, 2017; 23(26): 4796-4805
Published online Jul 14, 2017. doi: 10.3748/wjg.v23.i26.4796
Published online Jul 14, 2017. doi: 10.3748/wjg.v23.i26.4796
Figure 1 Activity of vWF: RCo in the Crohn’s disease group and the controls.
CD: Crohn’s disease.
Figure 2 Occurrence of vWF:Ag > 150%, vWF:RCo/vWF: Ag < 0.
7 and vWF: CB/vWF:Ag < 0.7 in patients with ulcerative colitis, Crohn’s disease and in the control group.
Figure 3 Correlation between selected haemostatic parameters and disease activity, and its duration.
A: Correlation between disease duration and vWF: CB in patients with UC; B: Correlation between disease activity and vWF: CB in patients with ulcerative colitis (UC); C: Correlation between disease activity and ADAMTS13:Ag in patients with UC. D: Correlation between disease activity and ADAMTS13act in patients with UC.
- Citation: Cibor D, Owczarek D, Butenas S, Salapa K, Mach T, Undas A. Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases. World J Gastroenterol 2017; 23(26): 4796-4805
- URL: https://www.wjgnet.com/1007-9327/full/v23/i26/4796.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i26.4796